Stockholders Approve Reverse Stock Split to Address Nasdaq Compliance

summarizeSummary

BIO-key stockholders approved a reverse stock split, giving the Board authority to implement it by May 6, 2026, to help regain Nasdaq compliance.

check_boxKey Events

• Reverse Stock Split Approved

  Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-10.

• Board Discretion on Ratio and Timing

  The Board of Directors has the authority to determine the exact ratio and timing of the reverse split, to be implemented no later than May 6, 2026.

• Addresses Nasdaq Non-Compliance

  This approval provides a mechanism for the company to potentially regain compliance with Nasdaq's minimum bid price requirement, following a recent non-compliance notice on April 22, 2026.

auto_awesomeAnalysis

This 8-K reports that BIO-key International's stockholders have approved a reverse stock split, a critical step for the micro-cap company to address its recent Nasdaq non-compliance notice. The Board now has discretion to implement a split ratio between 1-for-2 and 1-for-10 by May 6, 2026. This action is essential for the company to potentially regain compliance with Nasdaq's minimum bid price requirement and avoid delisting, which would severely impact its ability to raise capital and investor confidence. This follows the Nasdaq non-compliance notice issued just two days prior on April 22, 2026.